Miragen Therapeutics Inc Receivables Turnover Ratio (MGEN), from the third quarter 2026 to the third quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Miragen Therapeutics Inc   (NASDAQ: MGEN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Miragen Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Miragen Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 1, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Miragen Therapeutics Inc in Sep 30 2026 quarter, has decreased to 365 days, compared to 12167 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector Miragen Therapeutics Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Miragen Therapeutics Inc Selling?


What is Receivable Turnover Ratio?





MGEN Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Jun 30 2025)
II. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Receivable Change 11908.87 % 69344.44 % - -82.46 % 4033.33 %
Y / Y Revenue Change 15228.57 % -67.73 % -89.21 % - -54.84 %
Receivable Turnover Ratio (TTM) 1 0.03 10.88 5.01 10.26
MGEN's Total Ranking # # # # #
Accounts Receivable average collection period days 366 13039 34 73 36
Seq. Receivable Change -60.29 % - - -77.02 % 129.63 %
Seq. Revenue Change 8967.61 % 278.67 % - - -80.91 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Miragen Therapeutics Inc 's Accounts Receivable $ 30 Millions Visit MGEN's Balance sheet
Miragen Therapeutics Inc 's Sales TTM $ 26 Millions Visit MGEN's Income Statement
Sources of MGEN's Revenues Visit MGEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MGEN's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MGEN's Growth Rates MGEN's Roa MGEN's Inventory Turnover Ratio MGEN's Dividend Comparisons
MGEN's Profitability Ratios MGEN's Roi MGEN's Asset Turnover Ratio MGEN's Dividend Growth
MGEN's Valuation Ratios MGEN's Roe MGEN's Financial Strength Ratios MGEN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Abcellera Biologics Inc   2.36 $ 67.858  Millions$ 28.783  Millions
Arbutus Biopharma Corp  2.02 $ 181.490  Millions$ 89.727  Millions
Bio Green Med Solution Inc   1.99 $ 2.234  Millions$ 1.123  Millions
Ocular Therapeutix Inc   1.73 $ 50.384  Millions$ 29.162  Millions
Heron Therapeutics Inc   1.71 $ 149.458  Millions$ 87.396  Millions
Amarin Corp Plcuk  1.50 $ 176.609  Millions$ 118.128  Millions
Cytomx Therapeutics Inc   1.38 $ 14.027  Millions$ 10.163  Millions
Cardiff Lexington Corporation  0.39 $ 9.066  Millions$ 23.022  Millions

Date modified: 2026-11-07T13:21:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.